A Non-CME Educational Program during the 2025 AAAAI/WAO Joint Congress: Expert Panel Discussion Featuring a Patient

Program Overview

Hereditary angioedema (HAE) is a rare disease that causes painful, unpredictable, and potentially life-threatening episodes of subcutaneous or mucosal swelling. Attacks can be a source of stress, anxiety, and may interfere with a person’s ability to live a normal life. In this activity, a patient-provider panel sheds light on the challenges of living with HAE and the promise emerging therapies hold for this patient population.

*This program is not certified for continuing education credit.

Credit Expired

Target Audience

Allergists/clinical immunologists, primary care, and pediatric clinicians

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the burden of hereditary angioedema (HAE) and the resulting multifaceted effects that it has on patients’ lives
  • Integrate objective tools for assessing quality-of-life in patients with HAE into clinical practice
  • Assess the ways novel HAE on-demand and prophylactic therapies may reduce the burden of treatment
  • Develop individualized HAE treatment plans that result in improved health outcomes and normalization of life

Activity Faculty

DrRiedl 1000x1000

Marc A. Riedl, MD, MS

Professor, Medicine
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief and Training Program Director
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA

William Lumry_800x1000

William R. Lumry, MD

Clinical Professor, Internal Medicine
University of Texas Southwestern Medical School
Dallas, TX

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources